Last reviewed · How we verify
Skin and Skin Structure Acinetobacter Infection
Approved treatments
- Unasyn · Bristol-Myers Squibb
- Unasyn · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Acinetobacter Infection patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Acinetobacter Infection treatment landscape brief
- Skin and Skin Structure Acinetobacter Infection treatment updates RSS
Frequently asked questions about Skin and Skin Structure Acinetobacter Infection
What drugs treat Skin and Skin Structure Acinetobacter Infection?
Tracked treatments include Unasyn, Pipracil.
What is the treatment for Skin and Skin Structure Acinetobacter Infection?
Standard treatment for Skin and Skin Structure Acinetobacter Infection includes Unasyn, Pipracil. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Skin and Skin Structure Acinetobacter Infection patent cliff · Skin and Skin Structure Acinetobacter Infection CI report
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Unasyn · Pfizer
- Treatment: Pipracil
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing